Paper10690882
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
Bone HG and 16 others. J Clin Endocrinol Metab, 2000. Cited by 202 papers, by iCite.
Cite this record
ConductScience Library. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. Papers, record 10690882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10690882
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alendronate | Major topic |
| Bone Density | Major topic |
| Estrogens, Conjugated (USP) | Major topic |
| Postmenopause | Major topic |
| Adult | |
| Aged | |
| Animals | |
| Biopsy | |
| Bone Remodeling | |
| Bone and Bones | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Horses | |
| Humans | |
| Middle Aged |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39868546 | Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/39868546 | PubMed |
| 39585849 | Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey. | PLoS One | 2024 | https://conductscience.org/library/papers/39585849 | PubMed |
| 39566720 | Effect of donepezil on bone metabolism among older adults with Alzheimer's disease. | Contemp Clin Trials | 2025 | https://conductscience.org/library/papers/39566720 | PubMed |
| 39530312 | Pilot study of the effect of surgical menopause on bone mineral density and quality in patients with gynecological malignancies. | J Obstet Gynaecol Res | 2025 | https://conductscience.org/library/papers/39530312 | PubMed |
| 39315499 | The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part II. | J Menopausal Med | 2024 | https://conductscience.org/library/papers/39315499 | PubMed |
| 39031177 | Severe atypical iliac wing fracture associated with long-term bisphosphonate use. | Skeletal Radiol | 2025 | https://conductscience.org/library/papers/39031177 | PubMed |
| 38477744 | Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy. | J Bone Miner Res | 2024 | https://conductscience.org/library/papers/38477744 | PubMed |
| 37130601 | Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. | BMJ | 2023 | https://conductscience.org/library/papers/37130601 | PubMed |
| 36837459 | The Impact of Progesterone and Estrogen on the Tooth Mobility. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/36837459 | PubMed |
| 34831656 | Association between Osteoporosis and Previous Statin Use: A Nested Case-Control Study. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34831656 | PubMed |
| 34724173 | The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density. | Drugs | 2021 | https://conductscience.org/library/papers/34724173 | PubMed |
| 34660852 | Dose-dependent effects of pharmaceutical treatments on bone matrix properties in ovariectomized rats. | Bone Rep | 2021 | https://conductscience.org/library/papers/34660852 | PubMed |
| 34531991 | Association of bone mineral density and depression in different bone sites and ages: A meta-analysis. | Food Sci Nutr | 2021 | https://conductscience.org/library/papers/34531991 | PubMed |
| 33240217 | Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33240217 | PubMed |
| 32588816 | Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. | Health Technol Assess | 2020 | https://conductscience.org/library/papers/32588816 | PubMed |
| 31950363 | Combined antisclerostin antibody and parathyroid hormone (1-34) synergistically enhance the healing of bone defects in ovariectomized rats. | Z Gerontol Geriatr | 2020 | https://conductscience.org/library/papers/31950363 | PubMed |
| 31558481 | Diagnosis of osteoporosis in statin-treated patients is dose-dependent. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/31558481 | PubMed |
| 31076895 | Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration. | J Bone Miner Metab | 2019 | https://conductscience.org/library/papers/31076895 | PubMed |
| 29392472 | Single-dose local administration of parathyroid hormone (1-34, PTH) with β-tricalcium phosphate/collagen (β-TCP/COL) enhances bone defect healing in ovariectomized rats. | J Bone Miner Metab | 2019 | https://conductscience.org/library/papers/29392472 | PubMed |
| 28667435 | Using Osteoporosis Therapies in Combination. | Curr Osteoporos Rep | 2017 | https://conductscience.org/library/papers/28667435 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10690882
GET https://conductscience.org/api/papers/v1/10690882/cited_by?page=2